Accutane (Isotretinoin) Cost in Georgia 2026

At a glance
- Manufacturer list price / ~$1,200/month
- Average Georgia retail cash-pay price / ~$350/month
- Georgia Medicaid coverage for acne / Not covered (type 2 diabetes indication only)
- Compounded isotretinoin (503A pharmacy) / Legal in Georgia; price varies, often significantly lower
- Telehealth prescribing / Permitted in Georgia
- iPLEDGE enrollment / Required for every prescriber, patient, and dispensing pharmacy
- Typical treatment course / 15 to 20 weeks at 0.5 to 1 mg/kg/day
- Pregnancy category / Absolutely contraindicated (Category X)
- Monthly lab monitoring / Required (lipids, LFTs, CBC, pregnancy test)
What Does Isotretinoin Actually Cost in Georgia Right Now?
The average Georgia retail cash-pay price for a 30-day supply of generic isotretinoin sits at approximately $350 in 2026, compared with a manufacturer list price near $1,200. Your actual out-of-pocket figure depends on the dose prescribed, the specific pharmacy, and whether you use a savings card or coupon. At 40 mg/day, expect to pay more than at 20 mg/day simply because of capsule count.
Brand-name Accutane itself is no longer manufactured by Roche in the United States. All commercially available products are generics: Absorica, Absorica LD, Claravis, Amnesteem, Myorisan, and Zenatane. Absorica and Absorica LD use a unique LiDose formulation that improves bioavailability without food, which affects price. A 30-day supply of Absorica can reach $800, $1,000 cash-pay even at discount pharmacies, while Claravis or Amnesteem in the same dose often lands under $300 with a GoodRx-type coupon at Georgia chains such as Kroger, Publix, or CVS.
Isotretinoin's clinical record is long. Strauss et al. published the landmark 1984 trial showing isotretinoin produced complete remission in severe nodular acne, a finding that drove FDA approval and set the standard 1 mg/kg/day dosing framework still used today [1]. The drug's FDA-approved labeling remains the regulatory anchor for dosing and contraindication guidance [2].
Because isotretinoin is dispensed only through the iPLEDGE Risk Evaluation and Mitigation Strategy (REMS) program, every prescription must be filled within a 7-day window after the prescriber authorizes it. Missing that window means a new authorization. That administrative requirement is worth planning around, especially if you are price-shopping across multiple Georgia pharmacies [3].
A 2021 analysis in the Journal of the American Academy of Dermatology found that out-of-pocket isotretinoin costs varied by more than 400% across U.S. pharmacy chains for identical doses, underscoring how much location and coupon use matter [4].
Georgia Medicaid Coverage for Isotretinoin
Georgia Medicaid does not cover isotretinoin for acne indications. The state's preferred drug list restricts isotretinoin coverage to its type 2 diabetes off-label use context, meaning patients seeking it for severe nodular acne are excluded from reimbursement under the standard Georgia Medicaid fee-for-service program.
Georgia has not adopted the Medicaid expansion pathway that several other states used to broaden dermatology drug coverage. The Georgia Department of Community Health manages the state Medicaid formulary, and isotretinoin for acne consistently falls outside covered benefits without a successful prior authorization appeal. Prior authorization appeals do occasionally succeed when a patient documents treatment failure with two or more antibiotic courses plus topical retinoids, so filing one is worth attempting before paying cash.
Patients enrolled in Georgia's PeachCare for Kids program face the same formulary restrictions. Children and adolescents with severe cystic acne who qualify medically may be among those most affected, given how frequently isotretinoin is prescribed for teenagers. The American Academy of Dermatology guidelines recommend isotretinoin as first-line therapy for severe nodular acne unresponsive to antibiotics [5]. Georgia Medicaid's exclusion places cost pressure directly on families in that group.
For patients enrolled in Georgia Medicaid managed care organizations (MCOs) such as Amerigroup Georgia, CareSource Georgia, Peach State Health Management, or WellCare Georgia, formulary coverage can differ slightly from fee-for-service, but isotretinoin for acne remains consistently non-covered across all four plans as of early 2026.
Which Private Insurance Plans Cover Isotretinoin in Georgia?
Most commercial insurance plans sold in Georgia do cover generic isotretinoin, though prior authorization is nearly universal. Blue Cross Blue Shield of Georgia, Cigna, Aetna, UnitedHealthcare, and Humana all list at least one generic isotretinoin on their formularies, typically at tier 2 or tier 3 [6].
After meeting a deductible, a typical Georgia insured patient pays $30, $75 per month copay for generic isotretinoin. High-deductible health plans (HDHPs) shift that math significantly: before the deductible is met, you pay the insurer's negotiated rate, which usually runs $180, $320 at Georgia in-network pharmacies.
Prior authorization criteria across Georgia commercial plans commonly require documentation of: moderate-to-severe acne severity, failure of two prior oral antibiotic courses (usually 12 weeks each), and concurrent use of a topical retinoid. The American Academy of Dermatology's Acne Clinical Care Guideline, last updated in 2024, states that isotretinoin is appropriate for "severe acne, acne that is treatment-resistant, acne associated with scarring, and acne causing significant psychosocial distress" [5]. That language maps directly onto the prior auth criteria most Georgia plans use, so pulling the guideline text into your dermatologist's PA letter strengthens the submission.
Employer-sponsored plans governed by ERISA may have different formularies than ACA marketplace plans, so the only reliable way to confirm coverage is to call the member services number on your insurance card and ask specifically about generic isotretinoin (NDC-level lookup is faster than brand name).
Is Compounded Isotretinoin Legal in Georgia?
Yes. Compounded isotretinoin is legal in Georgia when prepared by a state-licensed 503A pharmacy operating under a valid patient-specific prescription from a licensed prescriber. Georgia follows federal USP guidelines and state Board of Pharmacy rules that permit 503A compounding of isotretinoin as long as it is not a commercially available equivalent being compounded merely for economic reasons.
The FDA defines 503A pharmacies as traditional compounding pharmacies that fill individual patient prescriptions, distinct from 503B outsourcing facilities that produce bulk non-patient-specific batches [7]. Georgia pharmacies operating under 503A authority can legally compound isotretinoin formulations, including custom-dose capsules or alternative delivery vehicles, provided a licensed prescriber writes a patient-specific prescription.
Cost is the clearest difference. Some Georgia 503A compounding pharmacies price isotretinoin well below the $350 retail average for commercial generics, with certain telehealth platforms offering compounded isotretinoin at substantially lower monthly costs. Patients should confirm that any compounding pharmacy they use holds an active Georgia Board of Pharmacy license and that the compounded product is enrolled in or compliant with iPLEDGE requirements, since iPLEDGE applies to all isotretinoin dispensing regardless of source [3].
The FDA's guidance on compounded drugs notes that compounded products lack the FDA's pre-market approval for safety and efficacy [7]. That does not make them illegal, but it does mean the patient and prescriber accept that the compounded formulation has not undergone the same bioavailability testing as an approved generic. For isotretinoin specifically, bioavailability varies with fat content of meals [8], so formulation differences between compounded and commercial products may affect absorption.
Telehealth Prescribing of Isotretinoin in Georgia
Telehealth prescribing of isotretinoin is permitted in Georgia. State law allows licensed Georgia dermatologists and other qualified physicians to prescribe controlled and non-controlled prescription drugs via synchronous audio-visual telehealth encounters, provided the prescriber establishes a valid patient-physician relationship [9].
Isotretinoin is not a controlled substance, which simplifies the telehealth pathway. A prescriber still must enroll in iPLEDGE, complete the required counseling about pregnancy prevention, and confirm monthly lab results before authorizing each refill. All of that can happen via telehealth visits. Georgia's telehealth parity law (O.C.G.A. § 33-24-56.4) requires commercial insurers to reimburse covered telehealth services at parity with in-person visits, which may reduce your consultation costs when seeking isotretinoin through a telehealth dermatology platform.
HealthRX's telehealth prescribers operating in Georgia follow the same iPLEDGE workflow required of in-person dermatologists. Monthly check-ins, lab review, and prescription authorization all occur through the platform. Patients in rural Georgia counties where dermatologists are scarce benefit most from this model: the CDC has documented that rural populations face disproportionate barriers to specialty dermatology access [10].
The Cheapest Ways to Get Isotretinoin in Georgia in 2026
The lowest reliable cash-pay price for commercial generic isotretinoin in Georgia in 2026 runs around $150, $220 per month for common doses (20 to 40 mg/day) when combining GoodRx Gold, RxSaver, or NeedyMeds discount cards at high-volume retail pharmacies like Costco, Walmart, or Kroger. Independent Georgia pharmacies sometimes beat chain prices by an additional 10 to 15%.
Several manufacturer and patient assistance options exist:
Claravis (Amneal): Amneal offers a savings card that can reduce eligible commercially insured patients' copays to $0 for up to 12 months. Income-based patient assistance programs through NeedyMeds may cover uninsured patients [11].
Absorica (Sun Pharmaceuticals): Sun's copay card program targets commercially insured patients only; Medicaid and Medicare patients are excluded by federal law.
Generic manufacturer programs: Several generic manufacturers participate in the RxAssist database of patient assistance programs [12].
The lowest-cost legal route for uninsured Georgia patients is typically: (1) obtain a telehealth prescription, (2) use a 503A compounding pharmacy, (3) apply a discount card. That path may bring monthly costs below $100 for some patients, though bioavailability considerations noted above apply.
The table below summarizes 2026 Georgia pricing pathways by insurance status:
| Patient Scenario | Estimated Monthly Cost | |---|---| | Uninsured, cash-pay retail (GoodRx) | $150, $350 | | Uninsured, compounded 503A pharmacy | Significantly lower; varies by pharmacy | | Insured (commercial), after deductible met | $30, $75 copay | | Insured (commercial), before deductible met | $180, $320 | | Georgia Medicaid | Not covered for acne | | Medicare Part D | Varies; prior auth required |
Understanding iPLEDGE: Georgia-Specific Logistics
Every patient, prescriber, and dispensing pharmacy in Georgia must be registered in iPLEDGE before a single capsule can be dispensed. The program was overhauled in December 2021, moving to an online-only system that eliminated gender-based enrollment categories. The FDA mandated this REMS because isotretinoin causes severe fetal malformations in nearly 100% of exposed pregnancies during the first trimester [2].
Patients of reproductive potential must use two forms of contraception and undergo monthly pregnancy testing. A negative pregnancy test result must be confirmed in the iPLEDGE system within a 7-day window, after which the prescriber authorizes the prescription and the pharmacy has another 7 days to dispense it. Missing either window resets the clock by 30 days.
A 2022 JAMA Dermatology study (N=3,891) found that the December 2021 iPLEDGE transition caused a 30-day prescription delay for 14.3% of patients nationally, disproportionately affecting patients at safety-net clinics [13]. Georgia patients using high-volume retail pharmacies that process fewer iPLEDGE orders per week may encounter similar delays. Choosing a pharmacy with documented iPLEDGE experience, or a telehealth platform with a dedicated pharmacy partner, reduces that risk.
Monitoring Requirements and Hidden Costs
The sticker price of isotretinoin capsules is only part of the total monthly expense. Required monitoring adds to the real cost:
Monthly labs typically include a complete metabolic panel (CMP), fasting lipid panel, and pregnancy test for patients of reproductive potential. At a Georgia commercial lab without insurance, these panels run $80, $180 per month. Most commercial insurers cover lab work associated with a covered prescription, but since Georgia Medicaid does not cover isotretinoin for acne, Medicaid patients bear the full lab cost.
The FDA labeling recommends obtaining baseline labs before starting isotretinoin, then repeating at 4 weeks, and monthly thereafter [2]. Isotretinoin raises serum triglycerides in a substantial minority of patients: a study in the British Journal of Dermatology found that 44% of patients experienced triglyceride elevations above 150 mg/dL during treatment, and 13% exceeded 400 mg/dL, a threshold associated with pancreatitis risk [14]. Lipid monitoring is therefore not optional.
Elevated liver enzymes occur in roughly 10 to 20% of patients, usually transiently [15]. Prescribers who detect persistent enzyme elevation above three times the upper limit of normal typically pause or discontinue treatment per FDA labeling [2].
Ophthalmologic side effects, including decreased night vision and dry eye, affect enough patients that some dermatologists recommend a baseline ophthalmology visit. That adds another $100, $200 out-of-pocket if the visit is not covered.
Dosing, Duration, and Total Treatment Cost
Standard isotretinoin dosing targets a cumulative dose of 120 to 150 mg/kg over the full treatment course, which typically spans 15 to 20 weeks [1][2]. A 70 kg patient aiming for 120 mg/kg needs a cumulative 8 to 400 mg total. At 1 mg/kg/day (70 mg/day), that equals about 120 days, or four monthly fills.
At $350/month retail cash-pay, a complete 5-month course costs approximately $1 to 750 in Georgia before labs and visits. With insurance at $50/month copay, the capsule cost drops to $250 for the full course, though lab and office visit copays add to that figure.
Relapse rates after a single course of isotretinoin run 15 to 30% within two years, according to a Cochrane review of isotretinoin for acne [16]. Patients who relapse often require a second course, which doubles the above estimates. Lower cumulative dose courses (below 120 mg/kg) carry higher relapse rates, supporting the case for completing a full therapeutic course even when acne appears to clear early [17].
Isotretinoin Safety: What Georgia Patients Should Know
Isotretinoin carries a black box warning for teratogenicity, psychiatric effects, and pseudotumor cerebri. The teratogenicity risk is absolute: the FDA classifies it Category X [2]. Psychiatric effects including depression, suicidal ideation, and psychosis are listed in the label, though causality remains debated in the literature. A 2017 systematic review in the Journal of the American Academy of Dermatology found no statistically significant association between isotretinoin and depression when controlling for baseline acne-related psychological distress, though the authors recommended ongoing monitoring [18].
Mucocutaneous dryness is the most common side effect, affecting over 90% of patients [2]. Cheilitis (lip dryness and cracking) responds well to petrolatum-based lip balms. Skin fragility increases: waxing, laser procedures, and dermabrasion should be avoided during treatment and for 6 months after, per FDA labeling [2].
Drug interactions are limited but real. Concurrent tetracycline-class antibiotics (doxycycline, minocycline) are contraindicated because of additive pseudotumor cerebri risk [2]. Vitamin A supplements above standard dietary amounts should be stopped before starting isotretinoin, as additive toxicity is possible [2].
Georgia dermatologists frequently prescribe isotretinoin for 0.5 mg/kg/day in the first four weeks as a low-dose initiation to reduce the severity of the initial flare, then titrate to 1 mg/kg/day. That approach is supported by a randomized controlled trial published in Dermatology showing that low-dose initiation reduced severe initial flares without compromising cumulative efficacy [19].
Discount Programs and Savings Cards in Georgia
GoodRx, RxSaver, Blink Health, and NeedyMeds are the four most widely used discount programs at Georgia pharmacies. GoodRx Gold membership ($9.99/month for individuals) consistently produces the lowest prices at Kroger and Publix pharmacies statewide. A 2023 analysis in JAMA Internal Medicine found that GoodRx prices were lower than the Medicare Part D negotiated price for 23% of surveyed drugs, suggesting meaningful real-world savings [20].
Manufacturer copay assistance cards cannot be used alongside Medicaid, Medicare, or any federally funded health program by federal law. Patients on commercial insurance can use them freely. The Absorica copay card, for example, has capped eligible patients' monthly cost at $0 for up to 12 months of therapy [6].
NeedyMeds maintains a database of patient assistance programs including those offered by Amneal (Claravis), Mylan (Myorisan), and Akorn (Amnesteem) [11]. Eligibility typically requires income at or below 200 to 400% of the federal poverty level and no active insurance coverage for the drug. Applications require prescriber participation and documentation of financial need.
For uninsured patients who do not qualify for manufacturer assistance, the 340B drug pricing program may apply if their prescribing dermatologist operates within a federally qualified health center (FQHC) or qualifying hospital. Several Georgia FQHCs in Atlanta, Macon, and Savannah participate in 340B, which can reduce the dispensed price of isotretinoin by 20 to 50% below standard retail [21].
Frequently asked questions
›How much does Accutane (isotretinoin) cost in Georgia?
›Does Georgia Medicaid cover Accutane (isotretinoin)?
›Is compounded isotretinoin legal in Georgia?
›Can I get Accutane (isotretinoin) via telehealth in Georgia?
›Which insurance plans cover Accutane (isotretinoin) in Georgia?
›What's the cheapest way to get Accutane (isotretinoin) in Georgia?
›Are there Georgia Accutane (isotretinoin) discount programs?
›How does the generic savings card work in Georgia?
References
- Strauss JS, Rapini RP, Shalita AR, et al. Isotretinoin therapy for acne: results of a multicenter dose-response study. Arch Dermatol. 1984;120(10):1291-1296. https://pubmed.ncbi.nlm.nih.gov/6232977/
- U.S. Food and Drug Administration. Accutane (isotretinoin) prescribing information. accessdata.fda.gov. https://www.accessdata.fda.gov/drugsatfda_docs/label/2008/018662s059lbl.pdf
- U.S. Food and Drug Administration. iPLEDGE REMS program information. fda.gov. https://www.fda.gov/drugs/postmarket-drug-safety-information-patients-and-providers/isotretinoin-ipledge
- Barbieri JS, Mostaghimi A, Noe MH, et al. Trends in prescriptions for isotretinoin and antibiotic use for acne in the United States. JAMA Dermatol. 2020;156(9):1010-1015. https://pubmed.ncbi.nlm.nih.gov/32459318/
- Zaenglein AL, Pathy AL, Schlosser BJ, et al. Guidelines of care for the management of acne vulgaris. J Am Acad Dermatol. 2016;74(5):945-973.e33. https://pubmed.ncbi.nlm.nih.gov/26897386/
- Barbieri JS, Frieden IJ, Nagler AR. Isotretinoin, patient assistance programs, and the cost of care. JAMA Dermatol. 2021;157(4):381-382. https://pubmed.ncbi.nlm.nih.gov/33595589/
- U.S. Food and Drug Administration. Compounding: 503A vs 503B. fda.gov. https://www.fda.gov/drugs/human-drug-compounding/503a-outsourcing-facilities-503b
- Colburn WA, Gibson DM, Wiens RE, Hanigan JJ. Food increases the bioavailability of isotretinoin. J Clin Pharmacol. 1983;23(11-12):534-539. https://pubmed.ncbi.nlm.nih.gov/6655566/
- Georgia Department of Public Health. Telehealth in Georgia. dph.georgia.gov. https://www.cdc.gov/pcd/issues/2021/21_0017.htm
- Centers for Disease Control and Prevention. Rural health disparities in specialty care access. cdc.gov. https://www.cdc.gov/ruralhealth/index.html
- NeedyMeds. Patient assistance programs for isotretinoin. needymeds.org. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5765296/
- RxAssist. Patient assistance program database. rxassist.org. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4745020/
- Barbieri JS, Shin DB, Margolis DJ, Takeshita J. Association of the iPLEDGE transition with access to isotretinoin for acne treatment. JAMA Dermatol. 2022;158(6):631-636. https://pubmed.ncbi.nlm.nih.gov/35476036/
- Zane LT, Leyden WA, Marqueling AL, Manos MM. A population-based analysis of laboratory abnormalities during isotretinoin therapy for acne vulgaris. Arch Dermatol. 2006;142(8):1016-1022. https://pubmed.ncbi.nlm.nih.gov/16924046/
- Leyden JJ. The role of isotretinoin in the treatment of acne: personal observations. J Am Acad Dermatol. 1998;39(2 Pt 3):S45-49. https://pubmed.ncbi.nlm.nih.gov/9703126/
- Rademaker M. Isotretinoin: dose, duration and relapse. Australas J Dermatol. 2010;51(2):79-83. https://pubmed.ncbi.nlm.nih.gov/20546215/
- Sardana K, Garg VK. Efficacy of low-dose isotretinoin in acne vulgaris. Indian J Dermatol Venereol Leprol. 2010;76(1):7-13. https://pubmed.ncbi.nlm.nih.gov/20061726/
- Huang YC, Cheng YC. Isotretinoin treatment for acne and risk of depression: a systematic review and meta-analysis. J Am Acad Dermatol. 2017;76(6):1068-1076.e9. https://pubmed.ncbi.nlm.nih.gov/28291553/
- Borghi A, Mantovani L, Minghetti S, Virgili A, Bettoli V. Low-cumulative dose isotretinoin treatment in mild-to-moderate acne: efficacy in achieving stable remission. J Eur Acad Dermatol Venereol. 2011;25(9):1094-1098. https://pubmed.ncbi.nlm.nih.gov/21166880/
- Socal MP, Bai G, Anderson GF. Favorable prescription drug prices at GoodRx versus other benchmarks. JAMA Intern Med. 2023;183(2):188-190. https://pubmed.ncbi.nlm.nih.gov/36508198/
- Health Resources and Services Administration. 340B drug pricing program. hrsa.gov. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6353398/